Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening

QR Code

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening

Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50±74 years to the more sensitive, but also less specific fecal immunochemical test (FIT). The aim of...

Full description

Bibliographic Details
Main Authors:	Goede, S., Rabeneck, L., Van Ballegooijen, M., Zauber, A., Paszat, L., Hoch, J., Yong, J., Kroep, S., Tinmouth, J., Lansdorp_Vogelaar, Iris
Format:	Journal Article
Published:	Public Library of Science 2017
Online Access:	http://hdl.handle.net/20.500.11937/52611

Similar Items

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

Fecal occult blood testing when colonoscopy capacity is limited
by: Wilschut, J., et al.
Published: (2011)

Colorectal cancer screening using immunochemical fecal occult blood test
by: Tan, Mun Chieng, et al.
Published: (2017)

Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
by: Kapidzic, A., et al.
Published: (2015)

Fecal immunochemical test-based colorectal cancer screening: The gender dilemma
by: Grobbee, E., et al.
Published: (2017)

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing
by: van der Vlugt, M., et al.
Published: (2017)

Do men and women need to be screened differently with fecal immunochemical testing? A cost-effectiveness analysis
by: Van Der Meulen, M., et al.
Published: (2017)

Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
by: Kapidzic, A., et al.
Published: (2015)

Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)

A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016)

Automated Fecal Parasite Detection System
by: Al-Sameraai, Raafat Salih Hadi, et al.
Published: (2013)

The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)

The fecal metabolome as a functional readout of the gut microbiome
by: Zierer, Jonas, et al.
Published: (2018)

Adsorption of Fecal Coliforms, Escherichia coli, in Soils of Sarawak
by: Ling, T. Y., et al.
Published: (2003)

Opportunities and challenges associated with fecal progesterone metabolite analysis
by: Peter, Innocent Damudu, et al.
Published: (2018)

The capacity of the fecal microbiota from Malawian infants to ferment resistant starch
by: Wang, Y., et al.
Published: (2019)

The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)

Applications of the Ecoli Bacteria Model In Predicting Fecal Coliforms In Surface Runoff
by: Ling, T. Y., et al.
Published: (2014)

Quantitative application of fecal sterols using gas chromatography−mass spectrometry to investigate fecal pollution in tropical waters: Western Malaysia and Mekong Delta, Vietnam
by: Isobe, Kei O., et al.
Published: (2002)

Rawatan fecal microbiota transplantation (FMT) menurut maqasid syariah
by: Nur Solihah Isa,, et al.
Published: (2022)

Adsorption of Fecal Coliforms, Escherichia Coli in different soils in Sarawak
by: Ling, Teck Yee, et al.
Published: (2003)

Fecal Coliform Bacteria Distribution in the Coastal Waters of Port Dickson
by: Law , A.T, et al.
Published: (1985)

New methods to assess fecal contamination in beach water quality
by: Praveena, Sarva Mangala, et al.
Published: (2015)

The in vitro digestibility study of fecal and feed sample of white rhinoceros
by: Abd. Latif, Muhammad Husaini
Published: (2017)

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)

Effect of Posterior Tibial Nerve Stimulation on Fecal Incontinence among Geriatrics
by: Agalya, S., et al.
Published: (2023)

Determination of fecal coliform and Escherichia coli (E.coli) in marine environment
by: Abdul Rashid, Mohamed Kamil
Published: (2011)

Comparative composition of fecal contents between broiler ducks and village chickens
by: Chong, Chiew Foong
Published: (2016)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling
by: Kroep, S., et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_aajtvapjg1gadugucbrlv4hfle